Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Osteopore Ltd. ( (AU:OSX) ).
Osteopore Limited has applied for quotation of 22,926 new fully paid ordinary shares on the ASX, to be issued on 7 April 2026 under the ticker OSX. The shares arise from the exercise or conversion of existing options or other convertible securities, modestly expanding the company’s quoted capital base and potentially enhancing liquidity for shareholders.
The application, lodged as an Appendix 2A with the ASX, reflects routine capital management activity rather than a broader strategic shift or transaction. While the issuance is relatively small in scale, it signals ongoing utilisation of equity-based instruments within Osteopore’s funding and incentive framework.
The most recent analyst rating on (AU:OSX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Osteopore Ltd. stock, see the AU:OSX Stock Forecast page.
More about Osteopore Ltd.
Osteopore Limited is a medical technology company listed on the ASX under the code OSX. The company is involved in developing and commercialising healthcare-related products, though this filing does not specify its particular medical specialisation, product range or target markets.
Average Trading Volume: 31,878,288
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.38M
Find detailed analytics on OSX stock on TipRanks’ Stock Analysis page.